İmatullah AKYAR, Deniz KOÇOĞLU TANYER, Esra ATAKUL

Geriatric Assessment in Oncology: G8 Screening Tool Validation and Reliability Study

OBJECTIVEThe present study aimed to test the validity and reliability of the Geriatrics 8 (G8) tool, a risk-screening toolfor further comprehensive geriatric assessment, with hematologic cancer patients aged 65 years and older.METHODSThis methodological study included 110 patients followed up for hematologic cancer. Data were collected using the patient identification form, the G8 screening tool, and the Edmonton Frail Scale. Languageand content validity, internal consistency, confirmatory factor, sensitivity and specificity and concurrentvalidity analyses were also used.RESULTSPatients (mean age: 73.9±6.10) were diagnosed with lymphoma (30.9%), multiple myeloma (21.8%),leukemia (20.9%), myelodysplastic syndrome (19.1%). Confirmatory factor model fit index analysis χ²/df and p-values (0.14) showed a good fit and GFI, AGFI, SRMR, and RMSEA values showed acceptablefit. The Cronbach’s alpha coefficient was 0.655, area under the ROC curve was 0.824 (95%, 0.745–0.904),and sensitivity and specificity were 61.0% and 88.9%, respectively.CONCLUSIONThe findings indicated that the G8 screening tool was found a valid and reliable tool for geriatric patientsdiagnosed with cancer to determine the risk and need for further comprehensive geriatric assessment.

PDF

___

1. Federal Interagency forum on Aging Related Statistics. Older Americans 2000: key indicators of well-being. 2002. Washington DC. Access: [https://agingstats. gov/docs/PastReports/2000/OA2000.pdf]. Accessed 22 April 2019.
2. Yancik R. Cancer burden in the aged: an epidemiologic and demographic overview. Cancer 1997;80(7):1273– 83.
3. Berger NA, Savvides P, Koroukian SM, Kahana EF, Deimling GT, Rose JH, et al. Cancer in the elderly. Trans Am Clin Climatol Assoc 2006;117:147−55.
4. Given B, Given CW. Older adults and cancer treatment. Cancer 2008;113(12 suppl): 3505−11.
5. Loh KP, Soto-Perez-de-Celis E, Hsu T, de Glas NA, Battisti NM, Baldini C, et al. What every oncologist should know about geriatric assessment for older patients with cancer: young international society of geriatric oncology position paper. J Oncol Pract. 2018;14(2):85−94.
6. Akdemir N, Akyar I. Geriatric nursing. J Acad Geriatr 2009;1(2):73−81.
7. Rubenstein LZ, Stuck AE, Siu AL, Wieland D. Impacts of geriatric evaluation and management programs on defined outcomes: overview of the evidence. J Am Geriatr Soc 1991;39(9 Pt 2):8−16.
8. Kane RL. Choosing and Using and Assessment Tool. In: Kane RL, Kane RA, editors. Assessing Older Persons: Measures, Meaning, and Practical Applications. 1st Edition. UK: Oxford University Press; 2004. p. 237−60.
9. Gallo J, Bogner HR. Multidimensional assessment. In: Gallo JJ, Bogner HR, Fulmer T, Paveza GJ, editors. Handbook of Geriatric Assessment. 4th Edition. USA: Jones & Bartlett Publishers; 2006. p. 6−11.
10.Extermann M, Aapro M, Bernabei R, Cohen HJ, Droz JP, Lichtman S, et al. Task Force on CGA of the International Society of Geriatric Oncology. Use of comprehensive geriatric assessment in older cancer patients: Recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG). Crit Rev Oncol Hematol 2005;55(3):241−52.
11.Droz JP, Balducci L, Bolla M, Emberton M, Fitzpatrick JM, Joniau S, et al. Management of prostate cancer in older men: recommendations of a working group of the International Society of Geriatric Oncology. BJU Int 2010;106(4):462−9.
12.NCCN Clinical Practice Guidelines in Oncology Senior Adult Oncology Version 2. 2011 [Internet]. National Comprehensive Cancer Network. [cited 2019 April 22]. Available at: http://www.nccn.org/professionals/physician_gls/pdf/senior.pdf. Accessed 2019, Oct 2.
13.International Society of Geriatric Oncology.Comprehensive Geriatric Assessment (CGA) of the older patient with cancer. SIOG [cited 2019 April 22]. Available from: http://www.siog.org/content/comprehensive-geriatric-assessment-cga-older-patientcancer.
14.Owusu C, Berger NA. Comprehensive geriatric assessment in the older cancer patient: coming of age in clinical cancer care. Clin Pract (Lond) 2014;11(6):749−62.
15.Yancik R, Ries LA. Cancer in older persons: an international issue in an aging world. Semin Oncol 2004;31(2):128−36.
16.Kalsi T, Babic-Illman G, Ross PJ, Maisey NR, Hughes S, Fields P, et al. The impact of comprehensive geriatric assessment interventions on tolerance to chemotherapy in older people. Br J Cancer 2015;112(9):1435−44.
17.Deschodt M, de Casterle BD, Milisen K. Gerontological care in nursing education programmes. J Adv Nurs 2010;66(1):139−48.
18.Puts MT, Hardt J, Monette J, Girre V, Springall E, Alibhai SM. Use of geriatric assessment for older adults in the oncology setting: a systematic review. J Natl Cancer Inst 2012;104(15):1133−63.
19.Kenis C, Decoster L, Van Puyvelde K, De Greve J, Conings G, Milisen K, et al. Performance of two geriatric screening tools in older patients with cancer. J Clin Oncol 2014;32(1):19−26.
20.Shahrokni A, Kim SJ, Bosl GJ, Korc-Grodzicki B. How we care for an older patient with cancer. J Oncol Pract 2017;13(2):95−102.
21.Marosi C, Köller M. Challenge of cancer in the elderly. ESMO Open 2016;1(3):e000020.
22.Overcash JA, Beckstead J, Moody L, Extermann M, Cobb S. The abbreviated comprehensive geriatric assessment (aCGA) for use in the older cancer patient as a prescreen: scoring and interpretation. Crit Rev Oncol Hematol 2006;59(3):205−10.
23.Hurria A, Gupta S, Zauderer M, Zuckerman EL, Cohen HJ, Muss H, et al. Developing a cancer‐specific geriatric assessment: A feasibility study. Cancer J 2005;104(9):1998−2005.
24.Hentschel L, Rentsch A, Lenz F, Hornemann B, Schmitt J, Baumann M, et al. A questionnaire study to assess the value of the vulnerable elders survey, G8, and predictors of toxicity as screening tools for frailty and toxicity in geriatric cancer patients. Oncol Res Treat 2016;39(4):210−6.
25.Soubeyran P, Bellera C, Goyard J, Heitz D, Cure H, Rousselot H, et al. Validation of the G8 screening tool in geriatric oncology: The ONCODAGE project. J Clin Oncol 2011;29(15 suppl):9001.
26.Bostankolu Ö, Öztürk B, Coşkun U, Büyükberber S, Benekli M. Cancer chemotherapy in elderly patients. Int J Hematol Oncol 2008;18(3):186−92.
27.Martinez-Tapia C, Canoui-Poitrine F, Bastuji-Garin S, Soubeyran P, Mathoulin-Pelissier S, Tournigand C, et al. Optimizing the G8 screening tool for older patients with cancer: diagnostic performance and validation of a six-item version. Oncologist 2016;21(2):188−95.
28.Bellera C, Rainfray M, Mathoulin-Pelissier S, Martens C, Delva F, Fonck, M, et al. Screening older cancer patients: first evaluation of the G-8 geriatric screening tool. Ann Oncol 2012; 23(8):2166−72.
29.Rolfson DB, Majumdar SR, Tsuyuki RT, Tahir A, Rockwood K. Validity and reliability of the Edmonton Frail Scale. Age Ageing 2006;35(5):526−9.
30.Aygör HE, Fadıloğlu Ç, Şahin S, Aykar FŞ, Akçiçek F. Validation of Edmonton Frail Scale into elderly Turkish population. Arch Gerontol Geriatr 2018;76:133−7.
31.Decoster L, Van Puyvelde K, Mohile S, Wedding U, Basso U, Colloca G, et al. Screening tools for multidimensional health problems warranting a geriatric assessment in older cancer patients: an update on SIOG recommendations. Ann Oncol 2015;26(2):288−300.
32.Balducci L, Beghe C. The application of the principles of geriatrics to the management of the older person with cancer. Crit Rev Oncol Hematol 2000;35(3):147−54.
33.Velghe A, Petrovic M, De Buyser S, Demuynck R, Noens L. Validation of the G8 screening tool in older patients with aggressive haematological malignancies. Eur J Oncol Nurs 2014;18(6):645−8.
34.Hamaker ME, Schiphorst AH, ten Bokkel Huinink D, Schaar C, van Munster BC. The effect of a geriatric evaluation on treatment decisions for older cancer patients–a systematic review. Acta Oncol 2014;53(3):289−96.